OmniAb (OABI) Non Operating Income (2023 - 2026)
OmniAb (OABI) reported Non Operating Income of $564000.0 for Q1 2026, up 4.83% year-over-year from $538000.0 in Q1 2025, and up 139.17% on a QoQ basis from -$1.4 million in Q4 2025.
OmniAb (OABI) has 4 years of Non Operating Income data on file, last reported at $564000.0 in Q1 2026.
- Quarterly Non Operating Income rose 4.83% year-over-year to $564000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$857000.0 (down 170.59% YoY) and the FY2025 annual result came in at $15000.0, up 200.0% from the prior year.
- Non Operating Income rose to $564000.0 in Q1 2026 per OABI's latest filing, from -$1.4 million in the prior quarter.
- Across five years, Non Operating Income topped out at $1.3 million in Q1 2023 and bottomed at -$3.9 million in Q4 2023.
- The 4-year median for Non Operating Income is $8000.0 (2023), against an average of -$93615.4.
- The widest annual swing landed in 2024, when Non Operating Income jumped 8437.5%; it then plunged 72100.0% in 2025.
- Tracing OABI's Non Operating Income over 4 years: stood at -$3.9 million in 2023, then jumped by 100.05% to $2000.0 in 2024, then sank by 72100.0% to -$1.4 million in 2025, then jumped by 139.17% to $564000.0 in 2026.
- Per Business Quant, the three latest OABI Non Operating Income figures stand at $564000.0 (Q1 2026), -$1.4 million (Q4 2025), and -$8000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 444,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 201.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -46.98 Mn |
| 10 | OmniAb | 334.72 Mn | 291.75 Mn | 14.41 Mn | 564,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 564,000.00 |
| Dec 31, 2025 | -1.44 Mn |
| Sep 30, 2025 | -8,000.00 |
| Jun 30, 2025 | 27,000.00 |
| Mar 31, 2025 | 538,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Sep 30, 2024 | 683,000.00 |
| Jun 30, 2024 | -9,000.00 |
| Mar 31, 2024 | 975,000.00 |
| Dec 31, 2023 | -3.88 Mn |
| Sep 30, 2023 | 8,000.00 |
| Jun 30, 2023 | -4,000.00 |
| Mar 31, 2023 | 1.32 Mn |